[1] D. Weigel, G. Jürgens, F. Küttner, E. Seifert, H. Jäckle, The homeotic gene fork head encodes a nuclear protein and is expressed in the terminal regions of the Drosophila embryo, Cell. 57 (1989) 645–658. doi:10.1016/0092-8674(89)90133-5.
[2] E. Lai, V.R. Prezioso, E. Smith, O. Litvin, R.H. Costa, J.E. Darnell, Transcnpuon Factor of Novel Structure Is Regulated Transcriptionally, (1990) 1427–1436.
[3] D. Weigel, H. Jäckle, The fork head domain: A novel DNA binding motif of eukaryotic transcription factors?, Cell. 63 (1990) 455–456. doi:10.1016/0092-8674(90)90439-L.
[4] K.H. Kaestner, W. Knöchel, D.E. Martínez, Unified nomenclature for the winged helix/forkhead transcription factors, Genes Dev. 14 (2000) 142–146. doi:10.1101/GAD.14.2.142.
[5] B.C. Jackson, C. Carpenter, D.W. Nebert, V. Vasiliou, Update of human and mouse forkhead box (FOX) gene families., Hum. Genomics. 4 (2010) 345–52. http://www.ncbi.nlm.nih.gov/pubmed/20650821%0Ahttp://www.pubmedcentral.nih.g ov/articlerender.fcgi?artid=PMC3500164.
[6] X. Wang, H. Kiyokawa, M.B. Dennewitz, R.H. Costa, The Forkhead Box m1b transcription factor is essential for hepatocyte DNA replication and mitosis during mouse liver regeneration, Proc. Natl. Acad. Sci. 99 (2002) 16881–16886. doi:10.1073/pnas.252570299.
[7] N.Y. Fu, B. Pal, Y. Chen, F.C. Jackling, M. Milevskiy, F. Vaillant, B.D. Capaldo, F. Guo, K.H. Liu, A.C. Rios, N. Lim, A.J. Kueh, D.M. Virshup, M.J. Herold, H.O. Tucker, G.K. Smyth, G.J. Lindeman, J.E. Visvader, Foxp1 Is Indispensable for Ductal Morphogenesis and Controls the Exit of Mammary Stem Cells from Quiescence, Dev. Cell. 47 (2018) 629–644.e8. doi:10.1016/j.devcel.2018.10.001.
[8] B.A. Benayoun, S. Caburet, R.A. Veitia, Forkhead transcription factors: Key players in health and disease, Trends Genet. 27 (2011) 224–232. doi:10.1016/j.tig.2011.03.003.
[9] M.L. Golson, K.H. Kaestner, Fox transcription factors: from development to disease, Development. 143 (2017) 4558–4570. doi:10.1242/dev.112672.
[10] Y.L. Zhang, F.T. Sun, Z. Zhang, X.X. Chen, A.X. Liu, J.J. Pan, F. Peng, S. Zhou, L.J. Sun, Comprehensive expression analysis suggests functional overlapping of human FOX transcription factors in cancer, Asian Pacific J. Cancer Prev. 15 (2014) 10475–10481. doi:10.7314/APJCP.2014.15.23.10475.
[11] L.L. Wang, Y.L. Xiu, X. Chen, K.X. Sun, S. Chen, D.D. Wu, B.L. Liu, Y. Zhao, The transcription factor FOXA1 induces epithelial ovarian cancer tumorigenesis and progression, Tumor Biol. 39 (2017) 1–7. doi:10.1177/1010428317706210.
[12] P. Laissue, The forkhead-box family of transcription factors: key molecular players in colorectal cancer pathogenesis, Mol. Cancer. 18 (2019) 1–13. doi:10.1186/s12943-019-0938-x.
[13] M.K. Park, Y. Yao, W. Xia, S.R. Setijono, J.H. Kim, I.K. Vila, H.H. Chiu, Y. Wu, E.G. Billalabeitia, M.G. Lee, R.G. Kalb, M.C. Hung, P.P. Pandolfi, S.J. Song, M.S. Song, PTEN self-regulates through USP11 via the PI3K-FOXO pathway to stabilize tumor suppression, Nat. Commun. 10 (2019) 636. doi:10.1038/s41467-019-08481-x.
[14] D.H. Bach, N.P. Long, T.T.T. Luu, N.H. Anh, S.W. Kwon, S.K. Lee, The dominant role of forkhead box proteins in cancer, Int. J. Mol. Sci. 19 (2018) 1–25. doi:10.3390/ijms19103279.
[15] S. Jägle, H. Busch, V. Freihen, S. Beyes, M. Schrempp, M. Boerries, A. Hecht, SNAIL1-mediated downregulation of FOXA proteins facilitates the inactivation of transcriptional enhancer elements at key epithelial genes in colorectal cancer cells, 2017. doi:10.1371/journal.pgen.1007109.
[16] L. Yang, K. He, S. Yan, Y. Yang, X. Gao, M. Zhang, Z. Xia, Z. Huang, S. Huang, N. Zhang, Metadherin/astrocyte elevated gene-1 positively regulates the stability and function of forkhead box M1 during tumorigenesis, Neuro. Oncol. 19 (2017) 352–363. doi:10.1093/neuonc/now229.
[17] C. Vorvis, M. Hatziapostolou, S. Mahurkar-Joshi, M. Koutsioumpa, J. Williams, T.R. Donahue, G.A. Poultsides, G. Eibl, D. Iliopoulos, Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer, Am. J. Physiol. - Gastrointest. Liver Physiol. 310 (2016) G1124–G1137. doi:10.1152/ajpgi.00035.2016.
[18] K. Miyamoto, T. Fukutomi, S. Akashi-Tanaka, T. Hasegawa, T. Asahara, T. Sugimura, T. Ushijima, Identification of 20 genes aberrantly methylated in human breast cancers, Int. J. Cancer. 116 (2005) 407–414. doi:10.1002/ijc.21054.
[19] E.H. Van Roon, A. Boot, A.A. Dihal, R.F. Ernst, T. Van Wezel, H. Morreau, J.M. Boer, BRAF mutation-specific promoter methylation of FOX genes in colorectal cancer, Clin. Epigenetics. 5 (2013) 1. doi:10.1186/1868-7083-5-2.
[20] C.P. Prasad, S. Mirza, G. Sharma, R. Prashad, S. DattaGupta, G. Rath, R. Ralhan, Epigenetic alterations of CDH1 and APC genes: Relationship with activation of Wnt/β-catenin Pathway in invasive ductal carcinoma of breast, Life Sci. 83 (2008) 318–325. doi:10.1016/j.lfs.2008.06.019.
[21] C. Management, JAM3 functions as a novel tumor suppressor and is inactivated by DNA methylation in colorectal cancer, (2019) 2457–2470.
[22] T. Ushijima, Detection and interpretation of altered methylation patterns in cancer cells, Nat. Rev. Cancer. 5 (2005) 223–231. doi:10.1038/nrc1571.
[23] T. Ushijima, M. Sasako, Focus on gastric cancer, Cancer Cell. 5 (2004) 121–125. doi:10.1016/s1535-6108(04)00033-9.
[24] P. Jones, S. Baylin, The Epigenomics of Cancer Peter, Cell. 128 (2007) 683–692. doi:10.1016/j.biotechadv.2011.08.021.Secreted.
[25] P.A. Jones, S.B. Baylin, The fundamental role of epigenetic events in cancer., Nat. Rev. Genet. 3 (2002) 415–28. doi:10.1038/nrg816.
[26] X. Cui, Y. Hartanto, H. Zhang, Advances in multicellular spheroids formation, J. R. Soc. Interface. 14 (2017). doi:10.1098/rsif.2016.0877.
[27] X. Jia, J. Eimer, A. Wagman, M.-R. Witt, S. Rehnmark, C. Verbeke, R. Toftgård, M. Löhr, R.L. Heuchel, 3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing., BMC Cancer. 13 (2013) 95. doi:10.1186/1471-2407-13-95.
[28] J. Wang, L.P. Guo, L.Z. Chen, Y.X. Zeng, H.L. Shih, Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line, Cancer Res. 67 (2007) 3716–3724. doi:10.1158/0008-5472.CAN-06-4343.
[29] J.M. Sung, H.J. Cho, H. Yi, C.H. Lee, H.S. Kim, D.K. Kim, A.M. Abd El-Aty, J.S. Kim, C.P. Landowski, M.A. Hediger, H.C. Shin, Characterization of a stem cell population in lung cancer A549 cells, Biochem. Biophys. Res. Commun. 371 (2008) 163–167. doi:10.1016/j.bbrc.2008.04.038.
[30] T. Chiba, S. Miyagi, A. Saraya, R. Aoki, A. Seki, Y. Morita, Y. Yonemitsu, O. Yokosuka, H. Taniguchi, H. Nakauchi, A. Iwama, The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma, Cancer Res. 68 (2008) 7742–7749. doi:10.1158/0008-5472.CAN-07-5882.
[31] K. Engelmann, H. Shen, O.J. Finn, MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1, Cancer Res. 68 (2008) 2419–2426. doi:10.1158/0008-5472.CAN-07-2249.
[32] P.P. Szotek, R. Pieretti-Vanmarcke, P.T. Masiakos, D.M. Dinulescu, D. Connolly, R. Foster, D. Dombkowski, F. Preffer, D.T. MacLaughlin, P.K. Donahoe, Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness, Proc. Natl. Acad. Sci. 103 (2006) 11154–11159. doi:10.1073/pnas.0603672103.
[33] M.R. Loebinger, A. Giangreco, K.R. Groot, L. Prichard, K. Allen, C. Simpson, L. Bazley, N. Navani, S. Tibrewal, D. Davies, S.M. Janes, Squamous cell cancers contain a side population of stem-like cells that are made chemosensitive by ABC transporter blockade, Br. J. Cancer. 98 (2008) 380–387. doi:10.1038/sj.bjc.6604185.
[34] T. Kondo, T. Setoguchi, T. Taga, Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line, Proc. Natl. Acad. Sci. 101 (2004) 781–786. doi:10.1073/pnas.0307618100.
[35] T. Chiba, K. Kita, Y.W. Zheng, O. Yokosuka, H. Saisho, A. Iwama, H. Nakauchi, H. Taniguchi, Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties, Hepatology. 44 (2006) 240–251. doi:10.1002/hep.21227.
[36] T. Nishii, M. Yashiro, O. Shinto, T. Sawada, M. Ohira, K. Hirakawa, Cancer stem cell-like SP cells have a high adhesion ability to the peritoneum in gastric carcinoma, Cancer Sci. 100 (2009) 1397–1402. doi:10.1111/j.1349-7006.2009.01211.x.
[37] J. Song, I. Chang, Z. Chen, M. Kang, C.Y. Wang, Characterization of side populations in HNSCC: Highly invasive, chemoresistant and abnormal Wnt signaling, PLoS One. 5 (2010) 1–9. doi:10.1371/journal.pone.0011456.
[38] J. Zhou, C.Y. Wang, T. Liu, B. Wu, F. Zhou, J.X. Xiong, H.S. Wu, J. Tao, G. Zhao, M. Yang, S.M. Gou, Persistence of side population cells with high drug efflux capacity in pancreatic cancer, World J. Gastroenterol. 14 (2008) 925–930. doi:10.3748/wjg.14.925.
[39] V.J. Bhagwandin, J.M. Bishop, W.E. Wright, J.W. Shay, The metastatic potential and chemoresistance of human pancreatic cancer stem cells, PLoS One. 11 (2016) 1–16. doi:10.1371/journal.pone.0148807.
[40] S. Borowicz, M. Van Scoyk, S. Avasarala, M.K. Karuppusamy Rathinam, J. Tauler, R.K. Bikkavilli, R.A. Winn, The Soft Agar Colony Formation Assay, J. Vis. Exp. (2014) 1–6. doi:10.3791/51998.
[41] S. Horibata, T. V. Vo, V. Subramanian, P.R. Thompson, S.A. Coonrod, Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells, J. Vis. Exp. (2015) 1–7. doi:10.3791/52727.
[42] B. Stephens, H. Han, G. Hostetter, M.J. Demeure, D.D. Von Hoff, Small interfering RNA-mediated knockdown of PRL phosphatases results in altered Akt phosphorylation and reduced clonogenicity of pancreatic cancer cells, Mol. Cancer Ther. 7 (2008) 202–210. doi:10.1158/1535-7163.mct-07-0542.
[43] R. Subramani, R. Lopez-Valdez, A. Arumugam, S. Nandy, T. Boopalan, R. Lakshmanaswamy, Targeting insulin-like growth factor 1 receptor inhibits pancreatic cancer growth and metastasis, PLoS One. 9 (2014). doi:10.1371/journal.pone.0097016.
[44] P.E. Oberstein, K.P. Olive, Pancreatic cancer: Why is it so hard to treat?, Therap. Adv. Gastroenterol. 6 (2013) 321–337. doi:10.1177/1756283X13478680.
[45] M. Uhlén, E. Björling, C. Agaton, C.A.-K. Szigyarto, B. Amini, E. Andersen, A.-C. Andersson, P. Angelidou, A. Asplund, C. Asplund, L. Berglund, K. Bergström, H. Brumer, D. Cerjan, M. Ekström, A. Elobeid, C. Eriksson, L. Fagerberg, R. Falk, J. Fall, M. Forsberg, M.G. Björklund, K. Gumbel, A. Halimi, I. Hallin, C. Hamsten, M. Hansson, M. Hedhammar, G. Hercules, C. Kampf, K. Larsson, M. Lindskog, W. Lodewyckx, J. Lund, J. Lundeberg, K. Magnusson, E. Malm, P. Nilsson, J. Ödling, P. Oksvold, I. Olsson, E. Öster, J. Ottosson, L. Paavilainen, A. Persson, R. Rimini, J. Rockberg, M. Runeson, Å. Sivertsson, A. Sköllermo, J. Steen, M. Stenvall, F. Sterky, S. Strömberg, M. Sundberg, H. Tegel, S. Tourle, E. Wahlund, A. Waldén, J. Wan, H. Wernérus, J. Westberg, K. Wester, U. Wrethagen, L.L. Xu, S. Hober, F. Pontén, A Human Protein Atlas for Normal and Cancer Tissues Based on Antibody Proteomics, Mol. Cell. Proteomics. 4 (2005) 1920–1932. doi:10.1074/mcp.M500279-MCP200.
[46] B. Sipos, S. Möser, H. Kalthoff, V. Török, M. Löhr, G. Klöppel, A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform., Virchows Arch. 442 (2003) 444–52. doi:10.1007/s00428-003-0784-4.
[47] A.M. Gutierrez-Barrera, D.G. Menter, J.L. Abbruzzese, S.A.G. Reddy, Establishment of three-dimensional cultures of human pancreatic duct epithelial cells., Biochem. Biophys. Res. Commun. 358 (2007) 698–703. doi:10.1016/j.bbrc.2007.04.166.
[48] M. Ozawa, H. Baribault, R. Kemler, The cytoplasmic domain of the cell adhesion, 8 (2004) 1–7. papers3://publication/uuid/DF5883A8-1CA1-472E-B7DE-9B567392C744.
[49] F.H. Brembeck, M. Rosário, W. Birchmeier, Balancing cell adhesion and Wnt signaling, the key role of β-catenin, Curr. Opin. Genet. Dev. 16 (2006) 51–59. doi:10.1016/j.gde.2005.12.007.
[50] T. Valenta, G. Hausmann, K. Basler, The many faces and functions of Î 2-catenin, EMBO J. 31 (2012) 2714–2736. doi:10.1038/emboj.2012.150.
[51] H. James Voeller, C.I. Truica, E.P. Gelmann, β-Catenin mutations in human prostate cancer, Cancer Res. 58 (1998) 2520–2523.
[52] M. Annick Buendia, Genetics of hepatocellular carcinoma, Semin. Cancer Biol. 10 (2000) 185–200. doi:10.1006/scbi.2000.0319.
[53] W.M. Clements, J. Wang, A. Sarnaik, O.J. Kim, J. MacDonald, C. Fenoglio-Preiser, J. Groden, A.M. Lowy, β-catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer, Cancer Res. 62 (2002) 3503–3506.
[54] H. Aberle, A. Bauer, A. Kispert, R. Kemler, Is a Target for the Ubiquitin–Proteasome Pathway, 16 (1997) 3797–3804.
[55] L.B. Weiswald, D. Bellet, V. Dangles-Marie, Spherical Cancer Models in Tumor Biology, Neoplasia (United States). 17 (2015) 1–15. doi:10.1016/j.neo.2014.12.004.
[56] W.G. Telford, J. Bradford, W. Godfrey, R.W. Robey, S.E. Bates, Side Population Analysis Using a Violet-Excited Cell-Permeable DNA Binding Dye, Stem Cells. 25 (2007) 1029–1036. doi:10.1634/stemcells.2006-0567.
[57] L. Wang, D.G. Heidt, C.J. Lee, H. Yang, C.D. Logsdon, L. Zhang, E.R. Fearon, M. Ljungman, D.M. Simeone, Oncogenic Function of ATDC in Pancreatic Cancer through Wnt Pathway Activation and β-Catenin Stabilization, Cancer Cell. 15 (2009) 207–219. doi:10.1016/j.ccr.2009.01.018.
[58] U.N. Verma, R.M. Surabhi, A. Schmaltieg, C. Becerra, R.B. Gaynor, Small interfering RNAs directed against β-catenin inhibit the in vitro and in vivo growth of colon cancer cells, Clin. Cancer Res. 9 (2003) 1291–1300. doi:10.1158/1078-0432.ccr-13-2017.
[59] S. Ghatak, S. Raha, Micro RNA-214 contributes to proteasome independent downregulation of beta catenin in Huntington’s disease knock-in striatal cell model STHdhQ111/Q111, Biochem. Biophys. Res. Commun. 459 (2015) 509–514. doi:10.1016/j.bbrc.2015.02.137.
[60] J. Su, A. Zhang, Z. Shi, F. Ma, P. Pu, T. Wang, J. Zhang, C. Kang, Q. Zhang, MicroRNA-200a suppresses the Wnt/β-catenin signaling pathway by interacting with β-catenin, Int. J. Oncol. 40 (2012) 1162–1170. doi:10.3892/ijo.2011.1322.
[61] K. Huang, J.-X. Zhang, L. Han, Y.-P. You, T. Jiang, P.-Y. Pu, C.-S. Kang, MicroRNA roles in beta-catenin pathway, Mol. Cancer. 9 (2010) 252. doi:10.1186/1476-4598-9-252.
[62] C. Behrends, M.E. Sowa, S.P. Gygi, J.W. Harper, Network organization of the human autophagy system., Nature. 466 (2010) 68–76. doi:10.1038/nature09204.
[63] K.J. Petherick, A.C. Williams, J.D. Lane, P. Ordóñez-Morán, J. Huelsken, T.J. Collard, H.J. Smartt, J. Batson, K. Malik, C. Paraskeva, A. Greenhough, Autolysosomal β-catenin degradation regulates Wnt-autophagy-p62 crosstalk, EMBO J. 32 (2013) 1903–1916. doi:10.1038/emboj.2013.123.
[64] B.A. Benayoun, F. Batista, J. Auer, A. Dipietromaria, D. L’Hôte, E. De Baere, R.A. Veitia, Positive and negative feedback regulates the transcription factor FOXL2 in response to cell stress: Evidence for a regulatory imbalance induced by disease-causing mutations, Hum. Mol. Genet. 18 (2009) 632–644. doi:10.1093/hmg/ddn389.
[65] S. Koch, Wnt activator FOXB2 drives prostate cancer neuroendocrine differentiation, BioRxiv. (2019) 1–32. doi:10.1101/564625.
[66] L. Lin, C.T. Miller, J.I. Contreras, M.S. Prescott, S.L. Dagenais, R. Wu, J. Yee, M.B. Orringer, D.E. Misek, S.M. Hanash, T.W. Glover, D.G. Beer, The hepatocyte nuclear factor 3 α gene, HNF3α (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas, Cancer Res. 62 (2002) 5273– 5279.
[67] C.M. Robbins, W.A. Tembe, A. Baker, S. Sinari, T.Y. Moses, S. Beckstrom-Sternberg, J. Beckstrom-Sternberg, M. Barrett, J. Long, A. Chinnaiyan, J. Lowey, E. Suh, J. V. Pearson, D.W. Craig, D.B. Agus, K.J. Pienta, J.D. Carpten, Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumors, Genome Res. 21 (2011) 47–55. doi:10.1101/gr.107961.110.
[68] C.S. Grasso, Y.M. Wu, D.R. Robinson, X. Cao, S.M. Dhanasekaran, A.P. Khan, M.J. Quist, X. Jing, R.J. Lonigro, J.C. Brenner, I.A. Asangani, B. Ateeq, S.Y. Chun, J. Siddiqui, L. Sam, M. Anstett, R. Mehra, J.R. Prensner, N. Palanisamy, G.A. Ryslik, F. Vandin, B.J. Raphael, L.P. Kunju, D.R. Rhodes, K.J. Pienta, A.M. Chinnaiyan, S.A. Tomlins, The mutational landscape of lethal castration-resistant prostate cancer, Nature. 487 (2012) 239–243. doi:10.1038/nature11125.
[69] D.C. Koboldt, R.S. Fulton, M.D. McLellan, H. Schmidt, J. Kalicki-Veizer, J.F. McMichael, L.L. Fulton, D.J. Dooling, L. Ding, E.R. Mardis, R.K. Wilson, A. Ally, M. Balasundaram, Y.S.N. Butterfield, R. Carlsen, C. Carter, A. Chu, E. Chuah, H.J.E. Chun, R.J.N. Coope, N. Dhalla, R. Guin, C. Hirst, M. Hirst, R.A. Holt, D. Lee, H.I. Li, M. Mayo, R.A. Moore, A.J. Mungall, E. Pleasance, A.G. Robertson, J.E. Schein, A. Shafiei, P. Sipahimalani, J.R. Slobodan, D. Stoll, A. Tam, N. Thiessen, R.J. Varhol, N. Wye, T. Zeng, Y. Zhao, I. Birol, S.J.M. Jones, M.A. Marra, A.D. Cherniack, G. Saksena, R.C. Onofrio, N.H. Pho, S.L. Carter, S.E. Schumacher, B. Tabak, B. Hernandez, J. Gentry, H. Nguyen, A. Crenshaw, K. Ardlie, R. Beroukhim, W. Winckler, G. Getz, S.B. Gabriel, M. Meyerson, L. Chin, R. Kucherlapati, K.A. Hoadley, J.T. Auman, C. Fan, Y.J. Turman, Y. Shi, L. Li, M.D. Topal, X. He, H.H. Chao, A. Prat, G.O. Silva, M.D. Iglesia, W. Zhao, J. Usary, J.S. Berg, M. Adams, J. Booker, J. Wu, A. Gulabani, T. Bodenheimer, A.P. Hoyle, J. V. Simons, M.G. Soloway, L.E. Mose, S.R. Jefferys, S. Balu, J.S. Parker, D.N. Hayes, C.M. Perou, S. Malik, S. Mahurkar, H. Shen, D.J. Weisenberger, T. Triche, P.H. Lai, M.S. Bootwalla, D.T. Maglinte, B.P. Berman, D.J. Van Den Berg, S.B. Baylin, P.W. Laird, C.J. Creighton, L.A. Donehower, M. Noble, D. Voet, N. Gehlenborg, D. Di Cara, J. Zhang, H. Zhang, C.J. Wu, S. Yingchun Liu, M.S. Lawrence, L. Zou, A. Sivachenko, P. Lin, P. Stojanov, R. Jing, J. Cho, R. Sinha, R.W. Park, M.D. Nazaire, J. Robinson, H. Thorvaldsdottir, J. Mesirov, P.J. Park, S. Reynolds, R.B. Kreisberg, B. Bernard, R. Bressler, T. Erkkila, J. Lin, V. Thorsson, W. Zhang, I. Shmulevich, G. Ciriello, N. Weinhold, N. Schultz, J. Gao, E. Cerami, B. Gross, A. Jacobsen, R. Sinha, B.A. Aksoy, Y. Antipin, B. Reva, R. Shen, B.S. Taylor, M. Ladanyi, C. Sander, P. Anur, P.T. Spellman, Y. Lu, W. Liu, R.R.G. Verhaak, G.B. Mills, R. Akbani, N. Zhang, B.M. Broom, T.D. Casasent, C. Wakefield, A.K. Unruh, K. Baggerly, K. Coombes, J.N. Weinstein, D. Haussler, C.C. Benz, J.M. Stuart, S.C. Benz, J. Zhu, C.C. Szeto, G.K. Scott, C. Yau, E.O. Paull, D. Carlin, C. Wong, A. Sokolov, J. Thusberg, S. Mooney, S. Ng, T.C. Goldstein, K. Ellrott, M. Grifford, C. Wilks, S. Ma, B. Craft, C. Yan, Y. Hu, D. Meerzaman, J.M. Gastier-Foster, J. Bowen, N.C. Ramirez, A.D. Black, R.E. Pyatt, P. White, E.J. Zmuda, J. Frick, T.M. Lichtenberg, R. Brookens, M.M. George, M.A. Gerken, H.A. Harper, K.M. Leraas, L.J. Wise, T.R. Tabler, C. McAllister, T. Barr, M. Hart-Kothari, K. Tarvin, C. Saller, G. Sandusky, C. Mitchell, M. V. Iacocca, J. Brown, B. Rabeno, C. Czerwinski, N. Petrelli, O. Dolzhansky, M. Abramov, O. Voronina, O. Potapova, J.R. Marks, W.M. Suchorska, D. Murawa, W. Kycler, M. Ibbs, K. Korski, A. Spychała, P. Murawa, J.J. Brzeziński, H. Perz, R. Łaźniak, M. Teresiak, H. Tatka, E. Leporowska, M. Bogusz-Czerniewicz, J. Malicki, A. Mackiewicz, M. Wiznerowicz, X. Van Le, B. Kohl, N. Viet Tien, R. Thorp, N. Van Bang, H. Sussman, B.D. Phu, R. Hajek, N.P. Hung, T.V.T. Phuong, H.Q. Thang, K.Z. Khan, R. Penny, D. Mallery, E. Curley, C. Shelton, P. Yena, J.N. Ingle, F.J. Couch, W.L. Lingle, T.A. King, A.M. Gonzalez-Angulo, M.D. Dyer, S. Liu, X. Meng, M. Patangan, F. Waldman, H. Stöppler, W.K. Rathmell, L. Thorne, M. Huang, L. Boice, A. Hill, C. Morrison, C. Gaudioso, W. Bshara, K. Daily, S.C. Egea, M.D. Pegram, C. Gomez-Fernandez, R. Dhir, R. Bhargava, A. Brufsky, C.D. Shriver, J.A. Hooke, J.L. Campbell, R.J. Mural, H. Hu, S. Somiari, C. Larson, B. Deyarmin, L. Kvecher, A.J. Kovatich, M.J. Ellis, T. Stricker, K. White, O. Olopade, C. Luo, Y. Chen, R. Bose, L.W. Chang, A.H. Beck, T. Pihl, M. Jensen, R. Sfeir, A. Kahn, A. Chu, P. Kothiyal, Z. Wang, E. Snyder, J. Pontius, B. Ayala, M. Backus, J. Walton, J. Baboud, D. Berton, M. Nicholls, D. Srinivasan, R. Raman, S. Girshik, P. Kigonya, S. Alonso, R. Sanbhadti, S. Barletta, D. Pot, M. Sheth, J.A. Demchok, K.R.M. Shaw, L. Yang, G. Eley, M.L. Ferguson, R.W. Tarnuzzer, J. Zhang, L.A.L. Dillon, K. Buetow, P. Fielding, B.A. Ozenberger, M.S. Guyer, H.J. Sofia, J.D. Palchik, Comprehensive molecular portraits of human breast tumours, Nature. 490 (2012) 61–70. doi:10.1038/nature11412.
[70] D.J. DeGraff, P.E. Clark, J.M. Cates, H. Yamashita, V.L. Robinson, X. Yu, M.E. Smolkin, S.S. Chang, M.S. Cookson, M.K. Herrick, S.F. Shariat, G.D. Steinberg, H.F. Frierson, X.R. Wu, D. Theodorescu, R.J. Matusik, Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation, PLoS One. 7 (2012). doi:10.1371/journal.pone.0036669.
[71] K.H. Kaestner, G. Schütz, A.P. Monaghan, Expression of the winged helix genes fkh-4 and fkh-5 defines domains in the central nervous system 1, Mech. Dev. 55 (1996) 221–230. doi:10.1016/0925-4773(96)00507-2.
[72] B.S. Pohl, S. Knöchel, K. Dillinger, W. Knöchel, Sequence and expression of FoxB2 (XFD-5) and FoxI1c (XFD-10) in Xenopus embryogenesis, Mech. Dev. 117 (2002) 283–287. doi:10.1016/S0925-4773(02)00184-3.
論文の公開元へ
